Also, studies showed that STT3A contributes to tumor immune escape by mediating the N-glycosylation of PD-L1, which enhances PD-L1 stability and surface expression, thereby suppressing CD8+ T cell–mediated antitumor responses (52). This evidence concerns the gene CD8A and neoplasm.